Friday, 10 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > How Medicare Says It Arrives At `Fair’ Prescription Drug Prices
Health and Wellness

How Medicare Says It Arrives At `Fair’ Prescription Drug Prices

Last updated: February 9, 2025 10:13 am
Share
How Medicare Says It Arrives At `Fair’ Prescription Drug Prices
SHARE

The Centers for Medicare and Medicaid Services (CMS) recently released justifications for the maximum fair prices it arrived at in negotiations with drug makers for the first 10 medications selected. This move sheds light on the process behind determining the so-called maximum fair prices and provides a glimpse into the negotiation strategies employed by the agency.

The Inflation Reduction Act signed into law by former President Biden in 2022 aimed to lower costs for Medicare beneficiaries by bringing down drug prices and capping out-of-pocket costs. The new Trump administration’s CMS confirmed that the Medicare Drug Price Negotiation Program is on track, but the specifics of the negotiations are yet to be revealed.

CMS announced maximum fair prices for the first ten outpatient drugs selected for negotiation last August. These prices are, on average, 22% lower than the net prices in 2023 and will take effect on January 1, 2026. The negotiation process involved offers and counteroffers between CMS and drug manufacturers.

To determine the initial offer price, CMS identified therapeutic alternatives for each selected drug and gathered pricing information for these competitors. The agency then adjusted the offer price based on the clinical benefit and safety profile of the drug relative to its competitors. Further adjustments were made based on data provided by manufacturers in their counteroffers.

Throughout the negotiation process, CMS considered factors such as therapeutic advances, clinical outcomes, and the impact on specific populations like people with disabilities and the elderly. The agency prioritized direct comparative evidence and evaluated comparative effectiveness data on patient-centered outcomes and experiences.

See also  Jay Leno Says Trump Election Win Was 'Fair': 'Great Day for Democracy'

One notable outcome of the negotiations was the difference in maximum fair prices reached for anticoagulant competitors Eliquis and Xarelto. Despite similar list prices, Eliquis’s maximum fair price was 17% higher than Xarelto’s, possibly due to clinical evidence differences. In another case, the cancer medication Imbruvica saw a significant price cut of approximately 38% due to the ceiling price stipulated by the IRA law.

While the justifications provided insight into the negotiation process, they did not detail how specific clinical and economic data factored into each negotiated maximum fair price. The rationales offered some information on the key value elements considered by CMS during the negotiations but left unanswered questions about the exact calculations and considerations behind the final prices.

Overall, the release of these justifications offers a peek behind the curtain of drug price negotiations under the new legislation, providing a better understanding of the factors and strategies at play in determining maximum fair prices for Medicare beneficiaries. The Trump administration’s CMS recently announced its commitment to incorporating lessons learned from the program and considering opportunities to bring greater transparency to the Negotiation Program. This signals a willingness to adapt and improve the program based on feedback and outcomes.

One key aspect of this commitment is the exploration of new negotiation methods, such as benchmarking overseas prices. This approach could potentially provide a more informed basis for pricing negotiations and help ensure that drug prices are fair and reasonable. By looking at prices in other countries, the program may be able to leverage this information to negotiate better deals with pharmaceutical companies.

See also  Preterm birth linked to higher blood pressure and anxiety in adults

The goal of greater transparency in the Negotiation Program is also significant. By making the negotiation process more transparent, stakeholders can better understand how drug prices are determined and how the program is working to lower costs. This can help build trust and accountability in the program, as well as provide valuable insights for future improvements.

It will be interesting to see how these changes are implemented and what impact they will have on drug pricing and access. The flexibility of the program to evolve and adapt under successive administrations is crucial for ensuring its effectiveness and relevance in addressing the challenges of rising drug costs.

Overall, the commitment to incorporating lessons learned and exploring new approaches in the Negotiation Program is a positive step towards improving healthcare affordability and access. By staying open to new ideas and feedback, the program can continue to make progress in addressing one of the most pressing issues in healthcare today.

TAGGED:ArrivesDrugfairMedicareprescriptionPrices
Share This Article
Twitter Email Copy Link Print
Previous Article Man killed, woman injured in shootings at Highlands Ranch Main Event Man killed, woman injured in shootings at Highlands Ranch Main Event
Next Article How 3D-printed parts changed the NASCAR Cup Series How 3D-printed parts changed the NASCAR Cup Series
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Apple Watch Series 11: Release Date, Price & Specs Rumours

The upcoming Apple Watch Series 11 is highly anticipated, building on the success of its…

February 7, 2025

Smooth And Bump-Free: Expert Tips On How To Prevent And Treat Ingrown Hairs

Sure! Below is a rewritten article that incorporates the key points, maintains a similar structure…

September 22, 2025

Jeff Bezos Plans to Build AI Data Centers in Space to Harness The Power of Solar Energy | The Gateway Pundit | by Ben Kew

In a bold announcement, former Amazon CEO and billionaire Jeff Bezos has unveiled an ambitious…

October 5, 2025

Six people hurt in attack at Colorado demonstration for Israeli hostages

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…

June 1, 2025

Can You Play Golf With A Bad Back? A Neurosurgeon’s Practical Guide

Golf is a beloved sport enjoyed by many, but for those dealing with persistent back…

July 31, 2025

You Might Also Like

STAT+: HHS employees to be fired as White House enacts mass terminations it blames on shutdown
Health and Wellness

STAT+: HHS employees to be fired as White House enacts mass terminations it blames on shutdown

October 10, 2025
Sugar Prices Retreat on a Forecast for a Global Sugar Surplus
Economy

Sugar Prices Retreat on a Forecast for a Global Sugar Surplus

October 10, 2025
No, circumcision doesn’t cause autism
Health and Wellness

No, circumcision doesn’t cause autism

October 10, 2025
Crude Oil Prices Rally on Energy Demand Optimism
Economy

Crude Oil Prices Rally on Energy Demand Optimism

October 10, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?